O
XNPT

OrbiMed’s XENOPORT, INC. XNPT Stock Holding History

OrbiMed’s Portfolio XNPT Stock Details XNPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-6,000,400
Closed -$27.1M – 153
2016
Q1 		$27.1M Buy
6,000,400
+232,000
+4% +$1.07M 0.28% 61
2015
Q4 		$31.7M Hold
5,768,400
– – 0.29% 63
2015
Q3 		$20M Hold
5,768,400
– – 0.2% 72
2015
Q2 		$35.4M Buy
5,768,400
+222,300
+4% +$1.45M 0.3% 65
2015
Q1 		$39.5M Hold
5,546,100
– – 0.34% 60
2014
Q4 		$48.6M Hold
5,546,100
– – 0.46% 52
2014
Q3 		$29.8M Hold
5,546,100
– – 0.31% 58
2014
Q2 		$26.8M Hold
5,546,100
– – 0.31% 58
2014
Q1 		$28.7M Buy
5,546,100
+955,300
+21% +$5.76M 0.35% 52
2013
Q4 		$26.4M Buy
4,590,800
+368,200
+9% +$1.99M 0.39% 56
2013
Q3 		$24M Buy
4,222,600
+181,800
+4% +$949K 0.43% 50
2013
Q2 		$20M Buy
+4,040,800
New +$24.5M 0.42% 47

Other funds holding XNPT

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CC
Coastland Capital Palo Alto, California $1.6B AUM 29.3% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

OrbiMed's XNPT Position: Q2 2016 in Review

OrbiMed sold out of XENOPORT, INC. (XNPT) in Q2 2016, closing a stake of 6,000,400 shares — an estimated $27.1M sold.

OrbiMed first reported a position in XNPT in Q2 2013 and held it in 12 quarters. The position peaked at $48.6M in Q4 2014. 107 funds tracked by Wall St. Rank hold XNPT as of Q2 2016.

  • OrbiMed reported no remaining XENOPORT, INC. position as of Q2 2016 after selling out during the quarter.
  • OrbiMed sold 6,000,400 XENOPORT, INC. shares in Q2 2016, an estimated $27.1M.
  • OrbiMed first reported a position in XENOPORT, INC. in Q2 2013 and held it in 12 quarters.
  • OrbiMed's XENOPORT, INC. position peaked at $48.6M in Q4 2014.
  • 107 funds tracked by Wall St. Rank held XENOPORT, INC. as of Q2 2016.

Based on OrbiMed's 13F filing for Q2 2016, filed 15 Aug 2016.